Life Tech Looks to Develop HLA Typing Assays for PGMGenomeWebAdditionally, the company has submitted a separate HLA typing assay for its 3500 Dx capillary electrophoresis sequencer to the US Food and Drug Administration for 510(k) clearance. Laird said…
TTU announces blood donation drive at residence halls – KCBD-TV
TTU announces blood donation drive at residence hallsKCBD-TVBy Brendan Lauritzen – email Texas Tech residence halls will host the first Battle for Blood donation. Students living on campus are encouraged to donate blood with United Blood services. The …
Kane coroner needs liver transplant, attorney says
Embattled Kane County Coroner Chuck West needs a liver transplant and might not be able to stand trial on misconduct charges that he was responsible for taking a television from the home of a dead Carpentersville man in May 2007.
Colloquium: Cincinnati Children's Hospital Named First Pediatric Heart Failure … – MarketWatch (press release)
Colloquium: Cincinnati Children's Hospital Named First Pediatric Heart Failure …MarketWatch (press release)COLUMBUS, Ohio, Apr 18, 2012 (BUSINESS WIRE) — The Healthcare Accreditation Colloquium announced today that the Heart Institute at Cincinn…
Vertex Advances INCIVEK™ (telaprevir) and Broad Portfolio of Medicines in Development With Goal of Further Expanding …
Vertex Pharmaceuticals Incorporated today announced data from a retrospective subanalysis of the Phase 2 PROVE 2 study that showed that 100 percent of patients with the IL28B CC genotype who were new to treatment achieved a viral cure with a total of 1…
Dick Clark reportedly died of heart failure Wednesday. – Chicago Daily Herald
The Epoch TimesDick Clark reportedly died of heart failure Wednesday.Chicago Daily HeraldAP/2001 By AP LOS ANGELES — Dick Clark, the ever-youthful television host and producer who helped bring rock 'n' roll into the mainstream on "Americ…
Abbott Laboratories Management Discusses Q1 2012 Results – Earnings Call … – Seeking Alpha
Abbott Laboratories Management Discusses Q1 2012 Results – Earnings Call …Seeking AlphaDaclizumab is a next-generation biologic in development for MS. Last year, Abbott and our partner company announced promising results from the first of 2 registrat…
Abbott Beats, Raises Outlook – Analyst Blog – NASDAQ
Abbott Beats, Raises Outlook – Analyst BlogNASDAQAbbott Labs, along with partner Biogen ( BIIB ), is evaluating daclizumab in a phase III study for the treatment of relapsing-remitting multiple sclerosis ( RRMS ). Abbott Labs is also working on an inte…
Scientists show lab-made heart cells ideal for disease research, drug testing – Medical Xpress
Scientists show lab-made heart cells ideal for disease research, drug testingMedical XpressThe finding used induced pluripotent stem, or iPS, cell technology to create heart-muscle-like cells from the skin of patients with dilated cardiomyopathy, which…
Abbott Beats, Raises Outlook – Zacks.com
Dividend.comAbbott Beats, Raises OutlookZacks.comAbbott Labs, along with partner Biogen (BIIB), is evaluating daclizumab in a phase III study for the treatment of relapsing-remitting multiple sclerosis (RRMS). Abbott Labs is also working on an intestin…